The SITC Forward Fund is pleased to announce the recipients of 2022 SITC Fellowships and Technology Awards, to support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of impactful research.
University of Florida Health pediatric oncologist John A. Ligon, M.D., has been awarded a $600,000 grant from the V Foundation for Cancer Research to study a personalized immunotherapy vaccine to treat relapsed pediatric osteosarcoma.
Manuela Corti, PhD and Tanja Taivassalo, PhD will lead a feasibility & efficacy study of Functional Electrical Stimulation (FES) cycling training to improve motor and cardiac functions in patients with Friedreich Ataxia. The purpose of this exploratory study is to assess the feasibility and…
As Lee Ramsey’s family watched him being transported by ambulance from the emergency room at Lawnwood Hospital in Ft. Pierce to UF Health in Gainesville, they were in need of reassurance. Lee was brought into the local emergency room because he was having difficulty breathing. When local doctors suggested that…
UF Health pediatrics expert Sonja A. Rasmussen, M.D., discusses what parents should know about the shots.
John Ligon, MD, from the University of Florida, was awarded the Outsmarting Osteosarcoma Because of Dylan Young Investigator Award and will study RNA-nanoparticle vaccines to overcome the immunosuppressive tumor microenvironment of canine osteosarcoma.
Two UF College of Medicine faculty members were recently recognized for their commitment to research and patient care at both the state and national levels.
University of Florida Health Shands Children’s Hospital continued its remarkable run as one of the Southeast’s premier pediatric medical centers as U.S. News & World Report Tuesday ranked it as Florida’s No. 1 children’s hospital, with five pediatric specialties earning the elite distinction of being rated among the nation’s…
Desmond Schatz, M.D., medical director of the Diabetes Institute at the UF College of Medicine, was recently elected to the Academy of Science, Engineering and Medicine of Florida (ASEMFL). The academy members elected Schatz for defining subjects at risk for type 1 diabetes and the genetic, immune and metabolic…
Dr. Rachel Coleman is using her experience to answer commonly asked questions.
